Skip to main navigation
Skip to search
Skip to main content
Monash University Home
Help & FAQ
Home
Profiles
Research units
Equipment
Projects
Outputs
Prizes
Activities
Press/Media
Search by expertise, name or affiliation
(ALIGN) - A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Atrasentan in Patients with IgA Nephropathy at Risk of Progressive Loss of Renal Function
Ryan, Jessica
(Primary Chief Investigator (PCI))
Medicine Monash Health
Project
:
Research
Overview
Project Details
Status
Active
Effective start/end date
7/05/21
→
6/05/26
View all
View less
Keywords
clinical trial
treatment safety
treatment efficacy
renal function
phase 3 study